Ageing in patients with chronic HIV infection: impact of hypercoagulation

Stephen J Kent1,2,3, Charles Flexner4

  • 1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC, 3010, Australia. skent@unimelb.edu.au.

AIDS Research and Therapy
|November 27, 2018
PubMed

Insights

People living with HIV experience accelerated ageing and age-related diseases. Understanding HIV

Area of Science:

  • Gerontology
  • Virology
  • Immunology

Background:

  • Ageing is a natural biological process leading to organ dysfunction and death.
  • HIV infection is increasingly perceived to accelerate the ageing process.
  • Antiretroviral therapy has improved life expectancy for people with HIV.

Purpose of the Study:

  • To provide an overview of ageing in the context of HIV infection.
  • To discuss how HIV complications impact the ageing process.
  • To explore the relationship between HIV and ageing to inform clinical management.

Main Methods:

  • Literature review and synthesis of existing research on HIV and ageing.
  • Analysis of the impact of HIV-related comorbidities on ageing.
  • Discussion of clinical implications for managing ageing HIV-positive patients.

Main Results:

  • People with HIV are ageing faster than the general population.
  • Increased life expectancy leads to a higher prevalence of age-related comorbidities in HIV-positive individuals.
  • HIV complications significantly influence the ageing trajectory.

Conclusions:

  • Effective management of ageing HIV-positive patients requires understanding the interplay between HIV and ageing.
  • Further research into HIV-ageing interactions can illuminate 'normal' ageing processes.
  • Clinicians need to address age-related comorbidities in the growing population of ageing individuals with HIV.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
236
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
703
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
262
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
253
Impact of Groups on Groups01:19

Impact of Groups on Groups

Social psychologists analyze how groups influence one another, shaping social structures and interactions through both cooperation and competition. These dynamics manifest in various ways, ranging from economic partnerships to intergroup conflicts that shape societal structures and perceptions.Cooperation and Competition in Intergroup RelationsIntergroup relationships vary across contexts, sometimes fostering cooperation and mutual benefit while at other times leading to conflict and...
247